Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

✍ Scribed by Hal E Broxmeyer; Attilio Orazi; Nancy L Hague; George W Sledge Jr.; Henrik Rasmussen; Michael S Gordon

• Book ID: 115589909
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 525 KB
• Volume: 24
• Category: Article
• ISSN: 1079-9796
• DOI: 10.1006/bcmd.1998.0167